References
- Ad Hoc Committee on Classification of Headache, (1962). Classification of headache. J. Amer. med. Ass., 179, 717.1. Ad Hoc Committee on Classification of Headache, (1962). Classification of headache. J. Amer. med. Ass., 179, 717.
- Dalsgaard-Nielsen, T., and Ulrick, J., (1973). Long-term effect and tolerance during prophylactic treatment of migraine with a benzo-cycloheptathiophene derivative, pizotifen. Headache, 13, 12–18.2. Dalsgaard-Nielsen, T., and Ulrick, J., (1973). Long-term effect and tolerance during prophylactic treatment of migraine with a benzo-cycloheptathiophene derivative, pizotifen. Headache, 13, 12–18.
- Ekbom, K., (1969). Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta. neurol. Scand., 45, 601–610.3. Ekbom, K., (1969). Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta. neurol. Scand., 45, 601–610.
- Forssman, B., Henriksson, K. g., and Kihlstrand, S., (1972). A comparison between BC 105 and methysergide in the prophylaxis of migraine. Acta, neurol. Scand., 48, 204–212.4. Forssman, B., Henriksson, K. g., and Kihlstrand, S., (1972). A comparison between BC 105 and methysergide in the prophylaxis of migraine. Acta, neurol. Scand., 48, 204–212.
- Hughes, R. C., and Foster, J. B., (1971). BC 105 in the prophylaxis of migraine. Curr. titer. Res., 13, 63–68.5. Hughes, R. C., and Foster, J. B., (1971). BC 105 in the prophylaxis of migraine. Curr. titer. Res., 13, 63–68.
- Lance, J. W., Anthony, M., and Somerville, B., (1970). Comparative trial of serotonin antagonists in the management of migraine. Brit. med. J., 2, 327–330.6. Lance, J. W., Anthony, M., and Somerville, B., (1970). Comparative trial of serotonin antagonists in the management of migraine. Brit. med. J., 2, 327–330.
- Nelson, R. F., (1973). BC 105 - a new prophylactic agent for migraine - four years' experience in seventy-five patients. Headache, 13, 96–103.7. Nelson, R. F., (1973). BC 105 - a new prophylactic agent for migraine - four years' experience in seventy-five patients. Headache, 13, 96–103.
- Olgiati, S., and Calobrisi, A., (1974). Clinical results with pizotyline in depression. Dis. nerv. Syst., 35, 35–38.8. Olgiati, S., and Calobrisi, A., (1974). Clinical results with pizotyline in depression. Dis. nerv. Syst., 35, 35–38.
- Sicuteri, F., Franchi, G., and Del Bianco, P. L., (1967). An antaminic drug, BC 105, in the prophylaxis of migraine. Int. Arch. Allergy, 31, 78–93.9. Sicuteri, F., Franchi, g., and Del Bianco, P. L., (1967). An antaminic drug, BC 105, in the prophylaxis of migraine. Int. Arch. Allergy, 31, 78–93.
- Sjaastad, O., and Stensrud, P., (1969). Appraisal of BC 105 in migraine prophylaxis. Acta. neurol. Scand., 45, 594–600.10. Sjaastad, O., and Stensrud, P., (1969). Appraisal of BC 105 in migraine prophylaxis. Acta. neurol. Scand., 45, 594–600.
- Tsougranis, A., (1972). Clinical study of orexigenic action of a new antiserotonin agent, BC 105 in patients with pulmonary tuberculosis. Curr. ther. Res., 14, 372–375.11. Tsougranis, A., (1972). Clinical study of orexigenic action of a new antiserotonin agent, BC 105 in patients with pulmonary tuberculosis. Curr. ther. Res., 14, 372–375.